The rapid diagnosis of sensitivity or resistance to dopamine agonists with depot bromocriptine.

The rapid diagnosis of sensitivity or resistance to dopamine agonists with depot bromocriptine.

Some patients with hyperprolactinaemia are unable to tolerate even low doses of oral bromocriptine. In such cases, it is difficult to predict whether serum prolactin might be normalized if higher doses could be tolerated, or whether true resistance to bromocriptine is present. We have investigated 8...

Полное описание

Библиографические подробности
Главные авторы:	Grossman, A, Wass, J, Besser, M
Формат:	Journal article
Язык:	English
Опубликовано:	1987

Схожие документы

Depot-bromocriptine treatment for prolactinomas and acromegaly.
по: Grossman, A, и др.
Опубликовано: (1986)

DEPOT BROMOCRIPTINE IN THE TREATMENT OF PROLACTINOMAS AND ACROMEGALY
по: Grossman, A, и др.
Опубликовано: (1985)

Terguride--a new dopamine agonist drug: a comparison of its neuroendocrine and side effect profile with bromocriptine.
по: Ciccarelli, E, и др.
Опубликовано: (1988)

Acute and long-term effects of once-daily oral bromocriptine and a new long-acting non-ergot dopamine agonist, quinagolide, in the treatment of hyperprolactinemia: a double-blind study.
по: Verhelst, J, и др.
Опубликовано: (1991)

Oral prednisolone supplement abolishes the acute adverse effects following initiation of depot bromocriptine therapy.
по: Jenkins, P, и др.
Опубликовано: (1996)

Incidence of heart valve disease in women treated with the ergot-derived dopamine agonist bromocriptine
по: Marianne F. Clausen, и др.
Опубликовано: (2021-12-01)

The effect of dopamine agonist therapy on large functionless pituitary tumours.
по: Grossman, A, и др.
Опубликовано: (1985)

The outcome of macroprolactinomas resistant to dopamine agonists
по: Coculescu, M, и др.
Опубликовано: (2005)

Bromocriptine, a Dopamine (D2 ) Receptor Agonist, Used Alone and in Combination with Glipizide in Sub–Therapeutic Doses to Ameliorate Hyperglycaemia
по: Harish Kumar V.S., и др.
Опубликовано: (2013-09-01)

Dopaminergic agonist bromocriptin in treatment of diabetes mellitus type 2
по: O A Gerasimenko, и др.
Опубликовано: (2011-12-01)

Two new dopamine agonists that are long acting in vivo but short acting in vitro.
по: Grossman, A, и др.
Опубликовано: (1980)

Bromocriptine and insulin sensitivity in lean and obese subjects
по: L Bahler, и др.
Опубликовано: (2016-11-01)

A bromocriptine-responsive corticotroph adenoma secreting alpha-MSH in a patient with Cushing's disease.
по: Hale, A, и др.
Опубликовано: (1988)

Trans-sphenoidal surgery for microprolactinoma: an acceptable alternative to dopamine agonists?
по: Turner, H, и др.
Опубликовано: (1999)

Dopamine D2 receptor agonist, bromocriptine, remodels adipose tissue dopaminergic signalling and upregulates catabolic pathways, improving metabolic profile in type 2 diabetes
по: G. Tavares, и др.
Опубликовано: (2021-09-01)

Long-term treatment with a new repeatable injectable form of bromocriptine, Parlodel LAR, in patients with tumorous hyperprolactinemia.
по: Ciccarelli, E, и др.
Опубликовано: (1989)

PROLACTINOMA IN A PREPUBERTAL CHILD - RESPONSE TO SURGERY, RADIOTHERAPY AND DOPAMINE AGONIST THERAPY
по: Sinn, D, и др.
Опубликовано: (1985)

Cabergoline or bromocriptine for prolactinoma?
по: Nicolás Triantafilo, и др.
Опубликовано: (2016-09-01)

A single sleeping midnight cortisol has 100% sensitivity for the diagnosis of Cushing's syndrome.
по: Newell-Price, J, и др.
Опубликовано: (1995)

Bromocriptine approved as the first medication to target dopamine activity to improve glycemic control in patients with type 2 diabetes
по: Michael A Via, и др.
Опубликовано: (2010-03-01)

Predictors of dopamine agonist resistance in prolactinoma patients
по: Elle Vermeulen, и др.
Опубликовано: (2020-05-01)

Central Hyperthermia Treated with Bromocriptine
по: P. Natteru, и др.
Опубликовано: (2017-01-01)

Bromocriptine in the Management of Central Hyperthermia
по: Krishnaprasad Narayanankutty, и др.
Опубликовано: (2024-08-01)

Repurposing of Bromocriptine for Cancer Therapy
по: Ean-Jeong Seo, и др.
Опубликовано: (2018-10-01)

Bromocriptine approved as the first medication to target dopamine activity to improve glycemic control in patients with type 2 diabetes
по: Via MA
Опубликовано: (2010-03-01)

Two new dopamine agonists that are long acting in vivo but short acting in vitro
по: Grossman, A, и др.
Опубликовано: (1980)

Resistance to Dopamine Agonists in Pituitary Tumors: Molecular Mechanisms
по: Claudia Pivonello, и др.
Опубликовано: (2022-01-01)

The Mechanism and Pathways of Dopamine and Dopamine Agonists in Prolactinomas
по: Xiaoshuang Liu, и др.
Опубликовано: (2019-01-01)

Dopamine agonist and tamoxifen combination therapy for a prolactin-secreting pituitary tumor resistant to dopamine agonist monotherapy: Case report and review
по: Zachary K. Christian, и др.
Опубликовано: (2020-09-01)

Bromocriptine in type 2 diabetes mellitus
по: C Shivaprasad, и др.
Опубликовано: (2011-01-01)

Bromocriptine for type 2 diabetes mellitus
по: Ooi, Cheow Peng, и др.
Опубликовано: (2013)

Clinical development of the GnRH agonist leuprolide acetate depot
по: Kristof Chwalisz, M.D., Ph.D.
Опубликовано: (2023-06-01)

Optimal dosage interval for depot somatostatin analogue therapy in acromegaly requires individual titration.
по: Jenkins, P, и др.
Опубликовано: (2000)

Dopamine Agonists and Pathologic Behaviors
по: Brendan J. Kelley, и др.
Опубликовано: (2012-01-01)

Bromocriptine use is associated with decreased smoking rates.
по: Murphy, M, и др.
Опубликовано: (2002)

Recurrence of hyperprolactinaemia following discontinuation of dopamine agonist therapy in patients with prolactinoma occurs commonly especially in macroprolactinoma.
по: Barber, T, и др.
Опубликовано: (2011)

The participation of hypothalamic dopamine in morphine-induced prolactin release in man.
по: Delitala, G, и др.
Опубликовано: (1983)

A comparison of cabergoline and bromocriptine in the treatment of hyperprolactinemic amenorrhea
по: Ismail, I.S., и др.
Опубликовано: (1994)

EFFECT OF OXYTOCIN AND BROMOCRIPTINE ON CORPORA LUTEA AND PSEUDOPREGNANCY IN MICE
по: N. A. S. AL- Khadi, и др.
Опубликовано: (1990-12-01)

A peripartum cardiomyopathy case treated with bromocriptine
по: Dilek Yeşilbursa, и др.
Опубликовано: (2021-03-01)